Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |